Bio-Rad Laboratories Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Bio-Rad Laboratories stock has a consensus rating of "Hold" and an average price target of $297. The average 1-year stock price forecast is 0.91% higher than the current stock price, while the lowest is $275 (-6.56%) and the highest is $320 (+8.73%).

Price Target: $297 (+0.91%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$275	$297	$300	$320
Change	-6.56%	+0.91%	+1.93%	+8.73%

Analyst Ratings

The average analyst rating for Bio-Rad Laboratories stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	1	0	0
Buy	0	0	0	0	0	1
Hold	3	3	3	3	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	4	4	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brandon Couillard Wells Fargo	Wells Fargo	Hold Maintains $290 → $310	Hold	Maintains	$290 → $310	+5.33%	May 22, 2026
Tycho Peterson Jefferies	Jefferies	Hold Maintains $275	Hold	Maintains	$275	-6.56%	May 21, 2026
Dan Leonard RBC Capital	RBC Capital	Buy Initiates $320	Buy	Initiates	$320	+8.73%	May 14, 2026
Patrick B Donnelly Citi	Citi	Hold Downgrades $375 → $300	Hold	Downgrades	$375 → $300	+1.93%	Apr 7, 2026

Financial Forecast

Revenue This Year

2.57B

from 2.58B

-0.62%

from 2.58B

Revenue Next Year

2.63B

from 2.57B

2.63%

from 2.57B

EPS This Year

9.00

from 9.92

-9.25%

from 9.92

EPS Next Year

9.72

from 9.00

7.99%

from 9.00

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	2.92B	2.80B	2.67B	2.57B	2.58B	2.57B
Revenue Growth	14.81%	-4.12%	-4.68%	-3.92%	0.65%	-0.62%
Gross Profit	1.66B	1.57B	1.43B	1.39B	1.34B	1.35B
Gross Margin	56.91%	55.93%	53.56%	54.30%	52.01%	52.70%
Operating Income	564.74M	482.60M	365.70M	289.20M	266.20M	266.76M
Net Income	4.25B	-3.63B	-637.30M	-1.84B	759.90M	224.84M
EPS	-	-	-	-	9.92	9.00
EPS Growth	-	-	-	-	-3.78%	-9.25%
Forward PE	59.87	28.66	26.51	28.85	28.94	32.69
Free Cash Flow	485.98M	2.86M	124.28M	193.49M	256.55M	311.85M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	2.6B
Avg	2.6B
Low	2.5B

Revenue Growth

Revenue Growth	2026	2027	2028
High	0.2%
Avg	-0.6%
Low	-2.0%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	9.00
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-9.3%
Low	-